Most lately, it's been discovered that conolidine and the above mentioned derivatives act within the atypical chemokine receptor 3 (ACKR3. Expressed in equivalent places as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor functions as being a scavenger https://billj221zkx7.wikimeglio.com/user